VulnerabilityAnalyzed

CVE-2026-21974

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform).

MEDIUM 5.3EPSS 0.23%

Does this matter?

Lower severity and a low EPSS score (0.23%). Track it; it rarely justifies an emergency change on its own.

Description

Vulnerability in the Oracle Life Sciences Central Designer product of Oracle Health Sciences Applications (component: Platform). The supported version that is affected is 7.0.1.0. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences Central Designer. Successful attacks of this vulnerability can result in unauthorized read access to a subset of Oracle Life Sciences Central Designer accessible data. CVSS 3.1 Base Score 5.3 (Confidentiality impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N).

CVSS 3.1: 5.3 MEDIUMCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N
EPSS: 0.23% probability · 14th percentile
CISA KEV: Not listed
Weakness: CWE-200
Affected: oracle/life sciences central designer
Source: secalert_us@oracle.com

References

https://www.oracle.com/security-alerts/cpujan2026.htmlVendor Advisory

Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.